Abstract
Purpose
To test the inter-reader agreement in classifying pulmonary hypertension (PH) on chest contrast-enhanced computed tomography (CECT) between a consensus of two cardio-pulmonary-devoted radiologists (CRc) and inexperienced readers (radiology residents, RRs) when using a CECT-based quick hands-on tool built upon PH imaging literature, i.e., the “Rapid Access and Practical Information Digest on Computed Tomography for PH-RAPID-CT-PH”.
Material and methods
The observational study retrospectively included 60 PH patients who underwent CECT between 2015 and 2022. Four RRs independently reviewed all CECTs and classified each case into one of the five PH groups per the 2022 ESC/ERS guidelines. While RR3 and RR4 (RAPID-CT-PH group) used RAPID-CT-PH, RR1 and RR2 (control group) did not. RAPID-CT-PH and control groups’ reports were compared with CRc using unweighted Cohen’s Kappa (k) statistics. RRs’ report completeness and reporting time were also compared using the Wilcoxon–Mann–Whitney test.
Results
The inter-reader agreement in classifying PH between the RAPID-CT-PH group and CRc was substantial (k = 0.75 for RR3 and k = 0.65 for RR4); while, it was only moderate for the control group (k = 0.57 for RR1 and k = 0.49 for RR2). Using RAPID-CT-PH resulted in significantly higher report completeness (all p < 0.0001) and significantly lower reporting time (p < 0.0001) compared to the control group.
Conclusion
RRs using RAPID-CT-PH showed a substantial agreement with CRc on CECT-based PH classification. RAPID-CT-PH improved report completeness and reduced reporting time. A quick hands-on tool for classifying PH on chest CECT may help inexperienced radiologists effectively contribute to the PH multidisciplinary team.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11547-024-01852-5.
Keywords: Pulmonary hypertension, Thoracic imaging, Chest computed tomography, Competency-based medical education
Introduction
Pulmonary hypertension (PH) is a multifactorial pulmonary vascular disorder that may be idiopathic or related to multiple clinical conditions, represented mainly by cardiac and respiratory diseases [1, 2]. The updated 2022 European Society of Cardiology / European Respiratory Society (ESC/ERS) guidelines define PH as the presence of mean pulmonary arterial pressure (PAP) values greater than 20 mmHg at rest, as determined by right heart catheterization [1]. PH is classified into five groups, including conditions with similar pathophysiological mechanisms and hemodynamic characteristics [1, 3]. The rationale behind this classification scheme relies on providing patients with the most appropriate management and treatment, which largely depend on inherent group-related differences, thus requiring a multidisciplinary approach [1, 3, 4].
When dealing with patients with suspected PH, the diagnostic challenge lies in identifying the causes early to institute prompt treatment [5]. In this light, chest contrast-enhanced computed tomography (CECT) plays a crucial role in suggesting the presence and possible etiology of PH [3, 6, 7] due to its anatomical comprehensiveness, allowing for integrated evaluation of lung, pulmonary vasculature, and mediastinal structures, including the heart [3, 6–8]. Given the clinical relevance of PH, radiologists’ active participation in the multidisciplinary PH team requires adequate knowledge and training in chest CECT imaging.
The appearance of PH on CECT is pleomorphic, encompassing various signs and patterns involving all the thoracic compartments [3, 6–8]. Therefore, one can assume that CECT reporting of PH requires experienced readers. However, the shortage of radiologists dedicated to this topic raises the question of what essential radiological information is needed to enable inexperienced readers to report a PH case knowingly, reliably, and rapidly. It is conceivable that this core consists not just of a set of distinct elements of sophisticated imaging features but of general patterns allowing for relevant clinical information concerning the PH phenotype. To our knowledge, no previous studies assessed the potential benefit inexperienced and/or non-dedicated chest radiologists might have from using an updated hands-on synopsis summarizing and organizing the CECT imaging findings of PH.
The primary aim was to evaluate the impact of using a quick hands-on tool for classifying PH on chest CECT (Rapid Access and Practical Information Digest on Computed Tomography for Pulmonary Hypertension, RAPID-CT-PH) on readers with limited experience in CT imaging and non-dedicated to thoracic imaging. We assessed the inter-reader agreement in assigning the PH group between four radiology residents (RRs) and two radiologists with cardio-pulmonary CT imaging expertise. The secondary objectives were to assess the impact of the RAPID-CT-PH on the agreement between inexperienced and experienced readers in formulating an etiological hypothesis of PH and its effect on the completeness of reports generated by inexperienced readers. Finally, we compared the CECT reading times using or not using the RAPID-CT-PH.
Material and methods
Our Institutional Review Board approved this monocentric, observational study and waived the acquisition of informed consent from patients due to the retrospective design.
Study design
Overall, we organized the study as follows (Fig. 1).
Fig. 1.
Graphical representation of the study organization (see the main text for details)
First, the study coordinator, i.e., a radiologist not involved in image reading, drafted the RAPID-CT-PH, a PH-dedicated quick hands-on tool based on the current literature evidence [6–25]. Two radiologists with 14 years of experience in cardio-pulmonary CT imaging (chest radiologist 1 [CR1] and chest radiologist 2 [CR2]) actively contributed to this task by reviewing and approving the final draft. The RAPID-CT-PH consisted of two parts: (i) A checklist of typical thoracic signs of PH to be identified on CECT; and (ii) a synoptic table series in which these signs are categorized within each PH group and subgroup. The signs included in the checklist are defined according to the glossary of terms for thoracic imaging from the Fleischner Society [26] and specific papers on PH chest computed tomography findings [6, 8, 12]. The two components forming the RAPID-CT-PH are shown in Fig. 2.
Fig. 2.
Rapid access and practical information digest on computed tomography for pulmonary hypertension (RAPID-CT-PH). A Checklist of typical chest computed tomography signs of pulmonary hypertension. B–F Synoptic table series categorizing chest computed tomography signs within each PH group and subgroup
Second, the study coordinator identified four radiology residents (RRs) attending the residency program at our University Hospital, including two senior residents in the last year of the program (radiology resident 1 [RR1] and radiology resident 3 [RR3]) and two novice residents at the beginning of their first year of the program with no previous experience in chest CT imaging (radiology resident 2 [RR2] and radiology resident 4 [RR4]).
Finally, all the residents (RR1-4) participated in a two-phase study, including a dedicated 2-h-long frontal teaching session focused on the chest CECT imaging role in patients with PH (“training” phase” of the study) and a subsequent case reading session, with or without the aid of the RAPID-CT-PH (“practical phase” of the study). Details are explained below.
Study population
By performing a computerized search, we identified all consecutive patients aged ≥ 18 years and diagnosed with PH who underwent a chest CECT in our Institution from 2015 to 2022. Patients were referred from the Cardiology Unit or the Rheumatology Clinic of our tertiary care University Hospital. Chest CECT was defined as a CT examination of the whole thorax after intravenous injection of iodinated contrast agent, utilizing two alternative protocols: CT pulmonary angiogram (CTPA) or venous-phase chest CT (VPCT). In the case of multiple available CECT scans, we considered the one closest to the PH diagnosis. According to 2022 ESC/ERS guidelines, PH was defined as the presence of a resting mean PAP > 20 mmHg on right heart catheterization or, in the case of unfeasible catheterization, highly probable PH on echocardiography [1]. Exclusion criteria encompassed unavailability of clinical data, prior cardiac surgery or lung transplantation history, and chest CECT examinations of non-diagnostic quality.
Of the 101 eligible subjects diagnosed with PH, we excluded 17 patients with unavailable CECT, 6 with unavailable clinical data, 3 with acute pulmonary infection potentially masquerading the PH imaging findings, 2 with prior cardiac surgery or lung transplantation history, and 13 because of chest CECT examinations of non-diagnostic quality. Therefore, the final population comprised 60 patients (25 men and 35 women; median age, 70 years; range, 41–85 years). The diagnosis of PH was based on right heart catheterization findings in 39/60 patients (mPAP values: median, 36.8 mmHg; range, 21–68 mmHg), the remaining 21/60 with a high-probability diagnosis on echocardiography. Fifty-three patients underwent chest CECT with CTPA protocol, the remaining 7 being VPCT.
Chest CECT examination technique
All the chest CECTs were performed on a 64-row computed tomography scanner (Discovery HD750 or Optima, GE Healthcare, Milwaukee, WI, USA), with the patient in the supine position, during inspiratory breath-hold, following intravenous administration of iodinated contrast medium (Iomeprol or Iobitridol, Bracco, Milan, Italy, with an Iodine concentration ranging from 350 to 400 mg/mL). The CTPA and VPCT technical parameters are reported in the supplementary material. The reconstruction sets included images with windowing and kernel dedicated to lung parenchyma (level, − 500 Hounsfield Units [HU]; width, 1700 HU; high-spatial-frequency algorithm) and soft tissues (level, 50 HU; width, 350 HU; standard algorithm). For CTPA examinations, images with arterial pulmonary vessel windowing (level, 100 HU; width, 700 HU) were also obtained.
Study phases, image analysis, and reference standard
Training phase
All the RRs, blinded to the study objectives, attended a dedicated 2 h-long frontal lecture held by CR1 and CR2. The lecture aimed to provide a shared theoretical basis for all the RRs and focused on the role, semiotics, and interpretation of chest CECT in patients with PH.
Practical phase
For each reader, the order of case presentation was randomized using freely available software (https://www.randomizer.org).
All RRs, independently and blinded to patient clinical, functional, and imaging data, reviewed all the CECT examinations. Their sole knowledge of clinical data was that all patients had confirmed PH diagnosis. For each CECT examination, the RRs were tasked with formulating a primary hypothesis regarding the PH group assignment. In cases of uncertainty, they were allowed to propose an alternative hypothesis for the PH group. Lastly, the RRs were required to indicate their presumed etiology of PH. For PH case reviewing and reporting, each RR disposed of a days’ number commensurate with the sample size, i.e., three consecutive working days stating 60 cases and a reasonable evaluation of 20 examinations per day.
The RRs were divided into two groups, each consisting of a senior and a novice RR. The groups included the “control” group, composed of RR1 (senior reader) and RR2 (novice reader), without any assistance for reporting the PH cases, and the “RAPID-CT-PH” group, composed of RR3 (senior reader) and RR4 (novice reader), both provided with the RAPID-CT-PH.
The consensus of CR1 and CR2 defined the reference standard (chest radiologists’ consensus, CRc) after they independently reviewed all CECT examinations, blinded to the patient’s clinical history except having been diagnosed with PH. CR1 and CR2 were given a reporting template with designated sections for “description” and “interpretation.” The “description” section comprised the twelve key features constituting the findings’ checklist in the RAPID-CT-PH. In the “interpretation” section, following the same approach as the RRs, they formulated a primary hypothesis regarding the PH group assignment and, in case of uncertainty, could propose an alternative PH group hypothesis. They also indicated the presumed PH etiology. Finally, all discrepancies were resolved through consensus (CRc), and a single PH group allocation hypothesis was selected for each case.
All CECT examinations were evaluated on a Picture Archiving and Communication System workstation (Suitestensa Ebit srl, Esaote Group Company, Genoa, Italy). The same software allowed the readers to multiplanar reconstructions and apply post-processing algorithms such as Maximum Intensity Projection (MIP), Minimum Intensity Projection (MinIP), and Average Intensity Projection (AIP) for more comprehensive image analysis.
Statistical analysis
The inter-reader agreement between each RR and CRc in classifying PH into the five groups as per the 2022 ESC/ERS guidelines [1] was determined using the unweighted Cohen’s Kappa statistic (k) with 95% confidence intervals (CI). Similarly, for the same classification task, we calculated the inter-reader agreement between RR1-RR2-CRc and RR3-RR4-CRc using the unweighted Fleiss’ kappa, and between RRs within the “control” group (RR1-RR2) and “RAPID-CT-PH” group (RR3-RR4) using the unweighted Cohen’s kappa. We deemed the agreement positive when the first or second-choice hypothesis for allocating the PH group provided by the RRs matched that of CRc. The k coefficient was interpreted as < 0.00, poor; 0.00–0.20, slight; 0.21–0.40, fair; 0.41–0.60, moderate; 0.61–0.80, substantial; 0.81–1.00, almost perfect [27].
The inter-reader agreement between each RR and CRc and between RRs within the “control” group and the “RAPID-CT-PH” group in producing an etiological hypothesis of PH was evaluated using Cohen’s kappa statistic. The same methodology outlined in the primary objective subsection was applied to this analysis. We focused on only PH group I and group III cases while excluding PH cases from groups II, IV, and V from the etiology analysis. Indeed, non-cardiac CT suffers from inherent limitations in assessing the heart and coronaries (group II), all the group IV cases in our series were due to CTEPH, and we had only one group V case.
The completeness of reports produced by the RRs was quantified using a completeness index. Initially, the index was expressed on a scale of 0–12 points, with each key feature being assigned one point and later converted to a scale of 0–100. The twelve key features considered were those reported in the RAPID-CT-PH and preliminarily presented to CR1 and CR2 (see above for details). The completeness indexes were calculated for each RR and compared between senior RRs (RR1 vs. RR3) and novice RRs (RR2 vs. RR4) using the Wilcoxon–Mann–Whitney test, as the data distribution did not follow a normal distribution as per the Kolmogorov–Smirnov test.
The average CECT reporting time was compared between RRs with and without the RAPID-CT-PH, i.e., reporting time of RR1-RR2 versus reporting time of RR3-RR4. The Wilcoxon–Mann–Whitney test was used for the comparison due to the non-normal distribution of the data.
To assess consistency between the CRc group hypothesis and the MDT-driven PH final group diagnosis, we calculated the CRc-MDT agreement in grouping PH using the percent agreement (PA) and the Prevalence and Bias Adjusted Kappa (PABAK) with 95%CI. Reference PABAK values were interpreted likewise the k coefficients.
Statistical analyses were conducted using R software version 3.4.2 (R Foundation for Statistical Computing, Vienna, Austria) and Single Case Research—web-based calculators for SCR analysis version 2.0, College Station, Texas. A significance level of 0.05 was used for all tests.
Results
CECT-based PH grouping and etiology according to the reference standard
Table 1 presents the distribution of CECT-defined case allocation across the five PH groups based on CRc readings. The two most prevalent PH groups were group II (21/60, 35%), which corresponds to PH associated with left heart disease, and group III (16/60, 26%), representing PH associated with lung diseases and/or hypoxia. Ten out of 60 patients (17%) were categorized as group IV PH, all attributed to chronic thrombo-embolic PH (CTEPH). Only one case was classified as group V PH, resulting from sarcoidosis. The remaining 12 out of 60 (20%) cases fell under group I PH, with connective tissue disease being the most hypothesized etiology (5/12 cases).
Table 1.
Distribution of chest contrast-enhanced computed tomography-defined case allocation across the five pulmonary hypertension groups based on the chest radiologists’ consensus readings
PHa grouping according to CRcb | PH etiology according to CRc | |||
---|---|---|---|---|
Group | Definition | N (%) | Subgroup etiology | N (%) |
I | Pulmonary arterial hypertension (PAH) | 12/60 (20) | 1.1 Idiopathic | 4/12 (33) |
1.4 Associated with: | ||||
1.4.1 Connective tissue disease | 5/12 (42) | |||
1.4.3 Portal hypertension | 2/12 (17) | |||
1.4.4 congenital heart disease | 1/12 (8) | |||
II | PH associated with left heart disease | 21/60 (35) | 2.1 Heart failure | 14/21 (66) |
2.2 Valvular heart disease | 7/21 (33) | |||
III | PH associated with lung diseases and/or hypoxia | 16/60 (26) | 3.1 Obstructive lung disease or emphysema | 4/16 (25) |
3.2 Restrictive lung disease | 8/16 (50) | |||
3.3 Lung diseases with mixed restrictive/obstructive pattern | 3/16 (19) | |||
3.4 Hypoventilation syndromes (e.g., obstructive sleep apnea) | 1/16 (6) | |||
IV | PH associated with pulmonary artery obstructions | 10/60 (6) | 4.1 Chronic thrombo-embolic PH (CTEPH) | 10/10 (100) |
V | PH with unclear and/or multifactorial mechanisms | 1/60 (1) |
5.2 Systemic disorders Sarcoidosis |
1/1 (100) |
aPulmonary hypertension
bChest radiologists’ consensus
The CRc-MDT agreement in grouping PH was almost perfect, with PA = 87% (52/60 cases) and PABAK = 0.83 (95%CI, 0.73–0.93).
Inter-reader agreement in classifying PH and hypothesizing its etiology
Table 2 reports the distribution of cases across PH groups, as categorized according to RRs. Group 2 PH was the most prevalent, with frequencies ranging from 28 to 50%.
Table 2.
Distribution of cases across pulmonary hypertension groups, as categorized according to the radiology residents
PHa group | RRb 1 N (%) |
RR 2 N (%) |
RR 3 N (%) |
RR 4 N (%) |
---|---|---|---|---|
I | 14/60 (23) | 18/60 (30) | 16/60 (26) | 18/60 (30) |
II | 23/60 (38) | 30/60 (50) | 17/60 (28) | 17/60 (28) |
III | 19/60 (15) | 8/60 (13) | 17/60 (28) | 13/60 (21) |
IV | 12/60 (20) | 3/60 (5) | 9/60 (15) | 11/60 (18) |
V | 2/60 (3) | 1/60 (1) | 1/60 (1) | 1/60 (1) |
aPulmonary hypertension
bRadiology resident
Table 3 shows the results of the inter-reader agreement analysis. The inter-reader agreement in classifying PH between the RRs who used RAPID-CT-PH and CRc was substantial for both the novice reader (RR4) and the senior reader (RR3); while, it was only moderate for the readers who did not employ it (RR1 and RR2). When comparing RRs within the same groups, the inter-reader agreement was fair (0.34) in the “control” group (RR1-RR2) and substantial (0.69) in the “RAPID-CT-PH” group (RR3-RR4).
Table 3.
Results of the inter-reader agreement analysis on pulmonary hypertension group allocation and etiology
PHa group allocation k [95%CI] |
PH etiology k [95%CI] |
|
---|---|---|
RR1b—CRcd Cohen’s kappa |
0.57 [0.42–0.73] Moderate |
0.43 [0.24–0.62] Moderate |
RR2b—CRc Cohen’s kappa |
0.49 [0.33–0.65] Moderate |
0.29 [0.12–0.47] Fair |
RR1—RR2—CRc Fleiss’ kappa |
0.46 [0.38–0.55] Moderate |
0.31 [0.24–0.38] Fair |
RR3c—CRc Cohen’s kappa |
0.75 [0.62–0.88] Substantial |
0.74 [0.57–0.91] Substantial |
RR4c—CRc Cohen’s kappa |
0.65 [0.50–0.79] Substantial |
0.66 [0.48–0.85] Substantial |
RR3—RR4—CRc Fleiss’ kappa |
0.69 [0.61–0.77] Substantial |
0.66 [0.57–0.74] Substantial |
aPulmonary hypertension
bRadiology residents not using RAPID-CT-PH
cRadiology residents using RAPID-CT-PH
dChest radiologists’ consensus
The inter-reader agreement with CRc regarding PH etiology was substantial when using RAPID-CT-PH (RR3 and RR4) and only fair-to-moderate for the readers who did not employ it (RR1 and RR2). When comparing RRs within the same groups, the inter-reader agreement was fair (0.25) in the “control” group and moderate (0.58) in the “RAPID-CT-PH” group.
Figure 3 visually represents the differences in agreement between RRs and CRc across the cases through dispersion diagrams. Example PH cases are shown in Figs. 4, 5.
Fig. 3.
Dispersion diagrams illustrating the differences in agreement across the cases between radiology residents and chest radiologists’ consensus (A) and between radiology residents of the same group (control group and RAPID-CT-PH group) (B)
Fig. 4.
Group I pulmonary hypertension in an 81-year-old woman. Images from CT pulmonary angiography examination show an abnormal return of the inferior vena cava to the left atrium (A, B), contrast medium jet directed from the left atrium to the right atrium (C), and lung mosaic attenuation pattern (D). The radiology residents in the control group did not identify the cardiovascular abnormality (RR2) or misclassified it (RR1); while, the ones in the RAPID-CT-PH group (RR3 and RR4) correctly identified and classified the condition
Fig. 5.
Group III pulmonary hypertension in an 84-year-old man. Images from CT pulmonary angiography examination show enlarged pulmonary artery (A), enlarged right heart chambers, with normal appearance of the left ones, and without signs of chronic thromboembolic disease (not shown) (B), and diffuse lung emphysema (C, D). The radiology residents in the control group (RR1 and RR2) misclassified the heart enlargement as a group II pulmonary hypertension; while, the ones in the RAPID-CT-PH group (RR3 and RR4) correctly identified and classified the condition
Chest CECT report completeness and reporting time
Table 4 reports the RRs’ report completeness indexes and reporting times. Using RAPID-CT-PH resulted in significantly higher completeness in CECT reports compared to those without it, regardless of RR expertise (all p < 0.0001). It also significantly reduced the reporting time (p < 0.0001), with a median of 15 min for RRs using RAPID-CT-PH (RR3-RR4) versus 20 min for those who did not (RR1-RR2).
Table 4.
Radiology residents’ report completeness indexes and reporting times
Report completeness index | Senior residents | Novice residents | ||
---|---|---|---|---|
RRa 1 without RAPID-CT-PH |
RR 3 with RAPID-CT-PH |
RR 2 without RAPID-CT-PH |
RR 4 with RAPID-CT-PH |
|
Median (IQR) [min–max] | 66.7 (16.7) [33.3–91.7] | 100 (0) [100–100] | 37.5 (0) [16.7–66.7] | 100 (8.33) [83.3–100] |
p-valuea | < 0.0001 | < 0.0001 |
Reporting time (minutes) |
Residents without RAPID-CT-PHb | Residents with RAPID-CT-PH |
---|---|---|
Median (IQR) [min–max] | 20 (5) [10–40] | 15 (9.75) [3–30] |
p-value* | < 0.0001 |
aRadiology resident
bRapid access and practical information digest on computed tomography for pulmonary hypertension
*Wilcoxon–Mann–Whitney test
Discussion
We found that the agreement between readers with limited experience in CT imaging (RRs) and radiologists with expertise in thoracic CT imaging (CRc) regarding chest CECT-based PH classification was substantial when the inexperienced readers utilized RAPID-CT-PH. Conversely, the agreement was only moderate when they did not use RAPID-CT-PH independently from being a novice or senior RR. To our knowledge, no previous studies have investigated the inter-reader agreement for classifying PH on chest CECT nor assessed how a quick hands-on tool could help inexperienced readers with such a task. Our results can be a valuable starting point for developing an educational PH-focused chest CT strategy within radiology residency programs or a practical tool aiding non-chest-devoted radiologists.
Several reasons may explain the higher agreement between RRs and CRc when using RAPID-CT-PH. First, RAPID-CT-PH includes a systematic checklist of CT findings, encompassing the various thoracic anatomical districts. Previous studies on CT imaging of different anatomical regions [28–30] demonstrated that utilizing a checklist of CT findings enables the identification of subtle signs with greater efficiency, going beyond the assessment of apparent findings and, in turn, improving diagnostic quality. Specifically, when dealing with chest imaging, the heart is often under-reported in non-dedicated CT examinations [31]. However, gathering valuable information on cardiac structures is possible even from a “routine” contrast-enhanced chest CT [32–34]. In PH patients, detectable cardiac anomalies include chamber enlargement, coarse valvular or coronary artery calcifications, gross intra- and extracardiac shunts, and atrial thrombi or masses [35]. In addition, explicitly seeking and reporting signs of pulmonary edema may suggest heart failure or valvular heart disease as causes of group II PH [36].
Second, RAPID-CT-PH incorporates a group-based organization of CT findings. This structured layout can assist inexperienced readers in conducting a comprehensive assessment of all the signs related to a particular group, thus integrating information from various anatomical regions. We hypothesize that visually complementing the list of findings in lung parenchyma, vessels, and mediastinum aided the RRs in reliably allocating PH group cases. This could be the case of PH group IV CECTs, wherein attention needs to be directed toward both pulmonary vessels and the lung [37, 38].
Third, RAPID-PH-CT was beneficial in assessing pulmonary abnormalities and assigning their relative priority compared to other findings. Specifically, compared to CRc, readers using RAPID-PH-CT effectively identified most group III PH cases (12/16 for RR4 and 16/16 for RR3). On the other hand, readers without RAPID-PH-CT properly allocated only around half of the cases (8/16 for RR1 and 7/16 for RR2). In clinical practice, distinguishing between group I and group III PH can be challenging [39], and physicians should reckon with cases displaying mixed PH phenotypes, i.e., cases that share characteristics of various PH groups rather than identify in a unique one [40]. Therefore, even if the final classification of PH derived from a comprehensive multidisciplinary evaluation may not accomplish the CT-derived hypothesis, the radiological assessment of parenchymal abnormalities remains critical. Indeed, CT-detected signs of lung fibrosis and emphysema in PH patients suggest chronic hypoxia [41] and are associated with significantly poorer survival, particularly when coupled with reduced DLCO [42].
The inter-reader agreement between RRs and CRc regarding PH etiology was substantial when using RAPID-CT-PH and only fair-to-moderate without employing it. We built RAPID-CT-PH as a comprehensive collection of complex CECT semiotics to organize imaging findings according to the thoracic anatomical districts, PH groups, and subgroup etiologies. It is worth underlining that CECT cannot claim to identify the PH etiology, and a multidisciplinary approach integrating imaging, functional, and laboratory tests is necessary to approach such a target. However, utilizing RAPID-CT-PH to browse the various conditions associated with each PH group may assist non-dedicated radiologists in avoiding the omission of subgroup-specific CT findings that can be subtle or not obvious, e.g., within group I PH, lung mosaic pattern or centrilobular ground-glass nodules in the “idiopathic form” [10], and macroscopic left-to-right cardiac shunts in the “congenital heart disease form” [1].
Using RAPID-CT-PH positively impacted the reporting completeness of chest CECT. Readers in the “control” group frequently omitted specific information that may be required for management decisions as part of the PH multidisciplinary evaluation. For instance, omitting to explicitly report the absence of notable lung abnormalities, e.g., fibrosis or emphysema, may require the referring clinician to subsequently contact the radiologist, ask for a second opinion, or even repeat the diagnostics, thus resulting in time and energy loss and, ultimately, potential management delays.
RAPID-CT-PH aided RRs in shortening the CECT reporting time. This result aligns with previous studies on diverse chest CT scenarios, e.g., COVID-19 pneumonia [43] and connective tissue diseases [44], showing the positive impact of digital supporting tools on the readers’ interpretation time. Of note, when using RAPID-CT-PH, RRs had a mean reporting time for chest CECT of 15 min, comparable (if not shorter) to large-scale radiology information system-derived radiologists’ mean reporting times, ranging from 17 to 19 min [45].
In the rising imaging-applied artificial intelligence (AI) era, emphasizing human intelligence (HI) may seem questionable. Contemporary RRs face increasing information demand on each imaging scenario, starting from the basics, such as terminology, definitions, and classifications. A direct comparison between HI and AI focusing solely on such “factual knowledge” components [46] would likely demonstrate the superiority of AI tools over humans. It has been advocated that prioritizing the reasoning processes involved in clinical-radiological integration, thereby operating at a higher level of knowledge, is essential to enhance RR education [47]. In response to this call, we set up this study involving RRs in a specific subspecialty topic, PH, to provide them with a challenge that could prototype a wide range of imaging scenarios. The present study aligns with endeavors toward implementing competency-based medical education (CBME) initiatives within radiology residency programs [48].
Some study limitations warrant mention. First, as the readers were aware that all cases were PH-confirmed, we did not evaluate the impact of RAPID-CT-PH in identifying PH in suspected cases. Therefore, no control cases without PH have been included in the study cohort. However, we intended RAPID-CT-PH to help classify rather than identify PH at CECT. We also believe that RAPID-CT-PH could provide a reliable basis for integrating chest CT-dedicated AI-driven tools. Further research is needed to explore the potential benefits of a human–machine partnership approach [49, 50], combining AI and HI to enhance imaging-derived PH phenotyping. Second, 7/60 CECTs were acquired via VPCT protocol, presumably less accurate in detecting the vascular signs of group IV PH (CTEPH). Due to the potential of VPCT protocol for effectively revealing signs related to the other PH groups [24], the influence of such a protocol heterogeneity on the reliability of PH classification is likely limited. Third, not all patients had an RHC-based diagnosis of PH; instead, a high probability of PH at echocardiography was used in 21 out of 60 cases. Although this may appear as a suboptimal patient selection, according to the 2022 ESC/ERS Guidelines on PH, RHC can be omitted in certain conditions, e.g., in patients with a high likelihood of left heart disease as the leading cause of PH [1]. We, therefore, believe this compromise does not undermine our results regarding RAPID-CT-PH. Last, this study was conducted at a single center with a small sample size, which may have led to an unbalanced distribution of cases among the groups, thus potentially hampering reproducibility. Indeed, we reported only one group V PH case related to sarcoidosis. Nonetheless, it is worth mentioning that most cases were attributed to left heart disease (group II PH), followed by lung disease (group III PH), which aligns with the frequencies reported in previous studies [2].
In conclusion, we observed substantial agreement on chest CECT-based PH classification between inexperienced readers using RAPID-CT-PH and expert radiologists. RAPID-CT-PH improved report completeness and reduced reporting time for chest CECT. Our results suggest that a quick hands-on tool for classifying PH on chest CECT can enable inexperienced radiologists to play a valuable role within the PH multidisciplinary team, thus impacting clinical decision-making. RAPID-CT-PH should be used early and systematically during the residency.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
Figure 1 was created with BioRender.com. We gratefully acknowledge the valuable assistance of Dr. Martina Meduri in graphic design and Dr. Valentino Collini for clinical support.
Author contributions
Lorenzo Cereser, Vincenzo Patruno, Chiara Zuiani, and Rossano Girometti contributed to the study conception and design. Gaia Zussino, Carmelo Cicciò, Annarita Tullio, Chiara Montanaro, Mauro Driussi, and Emma Di Poi performed material preparation, data collection, and analysis. Lorenzo Cereser and Gaia Zussino wrote the first draft of the manuscript. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Funding
Open access funding provided by Università degli Studi di Udine within the CRUI-CARE Agreement. The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
The Department of Medicine Institutional Review Board of the University of Udine approved the study (Rif. Prot. IRB 48/2023).
Consent to participate
This retrospective cohort study was performed in accordance with the principles of the Declaration of Helsinki. The study was approved by the Department of Medicine Institutional Review Board of the University of Udine (Rif. Prot. IRB 48/2023). The informed consent from patients to study participation was waived due to its retrospective nature.
Consent to publish
All the authors give the consent to publish the paper.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, ESC/ERS Scientific Document Group (2023) 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61(1):2200879. 10.1183/13993003.00879-2022 10.1183/13993003.00879-2022 [DOI] [PubMed] [Google Scholar]
- 2.Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, Jing ZC, Gibbs JS (2016) A global view of pulmonary hypertension. Lancet Respir Med 4(4):306–322. 10.1016/S2213-2600(15)00543-3 10.1016/S2213-2600(15)00543-3 [DOI] [PubMed] [Google Scholar]
- 3.Remy-Jardin M, Ryerson CJ, Schiebler ML, Leung ANC, Wild JM, Hoeper MM, Alderson PO, Goodman LR, Mayo J, Haramati LB, Ohno Y, Thistlethwaite P, van Beek EJR, Knight SL, Lynch DA, Rubin GD, Humbert M (2021) Imaging of pulmonary hypertension in adults: a position paper from the fleischner society. Radiology 298(3):531–549. 10.1148/radiol.2020203108 10.1148/radiol.2020203108 [DOI] [PubMed] [Google Scholar]
- 4.Opitz CF, Hoeper MM, Gibbs JS, Kaemmerer H, Pepke-Zaba J, Coghlan JG, Scelsi L, D’Alto M, Olsson KM, Ulrich S, Scholtz W, Schulz U, Grünig E, Vizza CD, Staehler G, Bruch L, Huscher D, Pittrow D, Rosenkranz S (2016) Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum. J Am Coll Cardiol 68(4):368–378. 10.1016/j.jacc.2016.05.047 10.1016/j.jacc.2016.05.047 [DOI] [PubMed] [Google Scholar]
- 5.Hassoun PM (2021) Pulmonary arterial hypertension. N Engl J Med 385(25):2361–2376. 10.1056/NEJMra2000348 10.1056/NEJMra2000348 [DOI] [PubMed] [Google Scholar]
- 6.Foley RW, Kaneria N, Ross RVM, Suntharalingam J, Hudson BJ, Rodrigues JC, Robinson G (2021) Computed tomography appearances of the lung parenchyma in pulmonary hypertension. Br J Radiol 94(1117):20200830. 10.1259/bjr.20200830 10.1259/bjr.20200830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.François CJ, Schiebler ML (2016) Imaging of pulmonary hypertension. Radiol Clin North Am 54(6):1133–1149. 10.1016/j.rcl.2016.05.011 10.1016/j.rcl.2016.05.011 [DOI] [PubMed] [Google Scholar]
- 8.Altschul E, Remy-Jardin M, Machnicki S, Sulica R, Moore JA, Singh A, Raoof S (2019) Imaging of pulmonary hypertension: pictorial essay. Chest 156(2):211–227. 10.1016/j.chest.2019.04.003 10.1016/j.chest.2019.04.003 [DOI] [PubMed] [Google Scholar]
- 9.Rajaram S, Swift AJ, Condliffe R, Johns C, Elliot CA, Hill C, Davies C, Hurdman J, Sabroe I, Wild JM, Kiely DG (2015) CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax 70(4):382–387. 10.1136/thoraxjnl-2014-206088 10.1136/thoraxjnl-2014-206088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Aluja Jaramillo F, Gutierrez FR, Díaz Telli FG, Yevenes Aravena S, Javidan-Nejad C, Bhalla S (2018) Approach to pulmonary hypertension: from CT to clinical diagnosis. Radiographics 38(2):357–373. 10.1148/rg.201817004611 10.1148/rg.201817004611 [DOI] [PubMed] [Google Scholar]
- 11.Grosse C, Grosse A (2010) CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 30(7):1753–1777. 10.1148/rg.307105710 10.1148/rg.307105710 [DOI] [PubMed] [Google Scholar]
- 12.Hoey ETD, Gopalan D, Agrawal SKB, Screaton NJ (2009) Cardiac causes of pulmonary arterial hypertension: assessment with multidetector CT. Eur Radiol 19(11):2557–2568. 10.1007/s00330-009-1460-0 10.1007/s00330-009-1460-0 [DOI] [PubMed] [Google Scholar]
- 13.Ali N, Loughborough WW, Rodrigues JCL, Suntharalingam J, Hudson B, Hall T, Augustine D, Mackenzie R, Robinson G (2019) Computed tomographic and clinical features of pulmonary veno-occlusive disease: raising the radiologist’s awareness. Clin Radiol 74(9):655–662. 10.1016/j.crad.2019.04.023 10.1016/j.crad.2019.04.023 [DOI] [PubMed] [Google Scholar]
- 14.Kumar N, Price LC, Montero MA, Dimopoulos K, Wells AU, Wort SJ (2015) Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Eur Respir J 46(4):1214–1217. 10.1183/13993003.00052-2015 10.1183/13993003.00052-2015 [DOI] [PubMed] [Google Scholar]
- 15.Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ, Xaubet A (2010) Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 30(6):1567–1586. 10.1148/rg.306105512 10.1148/rg.306105512 [DOI] [PubMed] [Google Scholar]
- 16.Foti G, Gobbi F, Angheben A, Faccioli N, Cicciò C, Carbognin G, Buonfrate D (2019) Radiographic and HRCT imaging findings of chronic pulmonary schistosomiasis: review of 10 consecutive cases. BJR Case Rep 5(3):20180088. 10.1259/bjrcr.20180088 10.1259/bjrcr.20180088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Coste F, Benlala I, Dournes G, Girodet PO, Laurent F, Berger P (2019) Assessing pulmonary hypertension in COPD. Is there a role for computed tomography? Int J Chron Obstruct Pulmon Dis 14:2065–2079. 10.2147/COPD.S207363 10.2147/COPD.S207363 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA, Chua AT, Corte TJ, Dalphin JC, Danoff SK, Diaz-Mendoza J, Duggal A, Egashira R, Ewing T, Gulati M, Inoue Y, Jenkins AR, Johannson KA, Johkoh T, Tamae-Kakazu M, Kitaichi M, Knight SL, Koschel D, Lederer DJ, Mageto Y, Maier LA, Matiz C, Morell F, Nicholson AG, Patolia S, Pereira CA, Renzoni EA, Salisbury ML, Selman M, Walsh SLF, Wuyts WA, Wilson KC (2020) Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 202(3):e36–e69. 10.1164/rccm.202005-2032ST 10.1164/rccm.202005-2032ST [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rossi A, Zompatori M, Tchouante Tchouanhou P, Amadori M, Palazzini M, Conficoni E, Galiè N, Poletti V, Gavelli G (2014) Rare causes of pulmonary hypertension: spectrum of radiological findings and review of the literature. Radiol Med 119(1):41–53. 10.1007/s11547-013-0305-8 10.1007/s11547-013-0305-8 [DOI] [PubMed] [Google Scholar]
- 20.Alves Júnior SF, Zanetti G, Melo ASAD, Souza AS Jr, Souza LS, Meirelles GDSP, Irion KL, Hochhegger B, Marchiori E (2019) Neurofibromatosis type 1: state-of-the-art review with emphasis on pulmonary involvement. Respir Med 149:9–15. 10.1016/j.rmed.2019.01.002 10.1016/j.rmed.2019.01.002 [DOI] [PubMed] [Google Scholar]
- 21.Borie R, Crestani B, Guyard A, Lidove O (2021) Interstitial lung disease in lysosomal storage disorders. Eur Respir Rev 30(160):200363. 10.1183/16000617.0363-2020 10.1183/16000617.0363-2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU (2022) Syndrome of combined pulmonary fibrosis and emphysema: an official ATS/ERS/JRS/ALAT research statement. Am J Respir Crit Care Med 206(4):e7–e41. 10.1164/rccm.202206-1041ST 10.1164/rccm.202206-1041ST [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Castoldi MC, Verrioli A, De Juli E, Vanzulli A (2014) Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging 5(4):483–492. 10.1007/s13244-014-0338-0 10.1007/s13244-014-0338-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Expert Panel on Thoracic Imaging, Sirajuddin A, Mirmomen SM, Henry TS, Kandathil A, Kelly AM, King CS, Kuzniewski CT, Lai AR, Lee E, Martin MD, Mehta P, Morris MF, Raptis CA, Roberge EA, Sandler KL, Donnelly EF (2022) ACR appropriateness criteria® suspected pulmonary hypertension: 2022 update. J Am Coll Radiol 19(11S):S502–S512. 10.1016/j.jacr.2022.09.018 10.1016/j.jacr.2022.09.018 [DOI] [PubMed] [Google Scholar]
- 25.Collini V, Driussi M, Nalli C, Baldassi M, Di Poi E, Cereser L, Giuliana F, Patruno V, Stolfo D, Sinagra G, Imazio M (2022) Leflunomide-induced pulmonary arterial hypertension: case report and review of literature. J Cardiol Cases 26(2):148–150. 10.1016/j.jccase.2022.04.001 10.1016/j.jccase.2022.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bankier AA, MacMahon H, Colby T, Gevenois PA, Goo JM, Leung ANC, Lynch DA, Schaefer-Prokop CM, Tomiyama N, Travis WD, Verschakelen JA, White CS, Naidich DP (2024) Fleischner society: glossary of terms for thoracic imaging. Radiology 310(2):e232558. 10.1148/radiol.232558 10.1148/radiol.232558 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174 10.2307/2529310 [DOI] [PubMed] [Google Scholar]
- 28.Dendl LM, Pausch AM, Hoffstetter P, Dornia C, Höllthaler J, Ernstberger A, Becker R, Kopf S, Schleder S, Schreyer AG (2021) Structured reporting of whole-body trauma ct scans using checklists: diagnostic accuracy of reporting radiologists depending on their level of experience. Rofo 193(12):1451–1460. 10.1055/a-1541-8265 10.1055/a-1541-8265 [DOI] [PubMed] [Google Scholar]
- 29.Lin E, Powell DK, Kagetsu NJ (2014) Efficacy of a checklist-style structured radiology reporting template in reducing resident misses on cervical spine computed tomography examinations. J Digit Imaging 27(5):588–593. 10.1007/s10278-014-9703-2 10.1007/s10278-014-9703-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Blum SFU, Hertzschuch D, Langer E, Schön F, Oppermann N, Kamin K, Kühn JP, Eberlein-Gonska M, Hoffmann RT (2023) Routine use of structured reporting in whole-body trauma CT facilitates quality improvement. Rofo 195(6):521–528. 10.1055/a-2031-2364 10.1055/a-2031-2364 [DOI] [PubMed] [Google Scholar]
- 31.Choy G, Kröpil P, Scherer A, El-Sherief AH, Chung J, Rojas CA, Abbara S (2013) Pertinent reportable incidental cardiac findings on chest CT without electrocardiography gating: review of 268 consecutive cases. Acta Radiol 54(4):396–400. 10.1177/0284185113475918 10.1177/0284185113475918 [DOI] [PubMed] [Google Scholar]
- 32.Krueger M, Cronin P, Sayyouh M, Kelly AM (2019) Significant incidental cardiac disease on thoracic CT: what the general radiologist needs to know. Insights Imaging 10(1):10. 10.1186/s13244-019-0693-y 10.1186/s13244-019-0693-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Verdini D, Lee AM, Prabhakar AM, Abbara S, Ghoshhajra B, Writing Group (2018) Detection of cardiac incidental findings on routine chest CT: the impact of dedicated training in cardiac imaging. J Am Coll Radiol 15(8):1153–1157. 10.1016/j.jacr.2016.02.011 10.1016/j.jacr.2016.02.011 [DOI] [PubMed] [Google Scholar]
- 34.Secchi F, Di Leo G, Zanardo M, Alì M, Cannaò PM, Sardanelli F (2017) Detection of incidental cardiac findings in noncardiac chest computed tomography. Medicine (Baltimore) 96(29):e7531. 10.1097/MD.0000000000007531 10.1097/MD.0000000000007531 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Melzig C, Do TD, Egenlauf B, Partovi S, Grünig E, Kauczor HU, Heussel CP, Rengier F (2022) Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease. Eur Radiol 32(8):5222–5232. 10.1007/s00330-022-08663-0 10.1007/s00330-022-08663-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mehra P, Mehta V, Sukhija R, Sinha AK, Gupta M, Girish MP, Aronow WS (2019) Pulmonary hypertension in left heart disease. Arch Med Sci 15(1):262–273. 10.5114/aoms.2017.68938 10.5114/aoms.2017.68938 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hahn LD, Papamatheakis DG, Fernandes TM, Poch DS, Yang J, Shen J, Hoh CK, Hsiao A, Kerr KM, Pretorius V, Madani MM, Kim NH, Kligerman SJ (2023) Multidisciplinary approach to chronic thromboembolic pulmonary hypertension: role of radiologists. Radiographics 43(2):e220078. 10.1148/rg.220078 10.1148/rg.220078 [DOI] [PubMed] [Google Scholar]
- 38.Yang J, Madani MM, Mahmud E, Kim NH (2023) Evaluation and management of chronic thromboembolic pulmonary hypertension. Chest 164(2):490–502. 10.1016/j.chest.2023.03.029 10.1016/j.chest.2023.03.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Olschewski H (2021) The challenge to decide between pulmonary hypertension due to chronic lung disease and PAH with chronic lung disease. Diagnostics (Basel) 11(2):311. 10.3390/diagnostics11020311 10.3390/diagnostics11020311 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mandras SA, Mehta HS, Vaidya (2020) Pulmonary hypertension: a brief guide for clinicians. Mayo Clin Proc 95(9):1978–1988. 10.1016/j.mayocp.2020.04.039 10.1016/j.mayocp.2020.04.039 [DOI] [PubMed] [Google Scholar]
- 41.Valentini A, Franchi P, Cicchetti G, Messana G, Chiffi G, Strappa C, Calandriello L, Del Ciello A, Farchione A, Preda L, Larici AR (2023) Pulmonary hypertension in chronic lung diseases: what role do radiologists play? Diagnostics (Basel) 13(9):1607. 10.3390/diagnostics13091607 10.3390/diagnostics13091607 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Dwivedi K, Condliffe R, Sharkey M, Lewis R, Alabed S, Rajaram S, Hill C, Saunders L, Metherall P, Alandejani F, Alkhanfar D, Wild JM, Lu H, Kiely DG, Swift AJ (2022) Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease. ERJ Open Res 8(1):00549–02021. 10.1183/23120541.00549-2021 10.1183/23120541.00549-2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Stanzione A, Ponsiglione A, Cuocolo R, Rumolo M, Santarsiere M, Scotto R, Viceconte G, Imbriaco M, Maurea S, Camera L, Gentile I, Brunetti A (2021) Chest CT in COVID-19 patients: structured vs conventional reporting. Eur J Radiol 138:109621. 10.1016/j.ejrad.2021.109621 10.1016/j.ejrad.2021.109621 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Cereser L, Marchesini F, Di Poi E, Quartuccio L, Zabotti A, Zuiani C, Girometti R (2022) Structured report improves radiology residents’ performance in reporting chest high-resolution computed tomography: a study in patients with connective tissue disease. Diagn Interv Radiol 28(6):569–575. 10.5152/dir.2022.21488 10.5152/dir.2022.21488 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cowan IA, MacDonald SL, Floyd RA (2013) Measuring and managing radiologist workload: measuring radiologist reporting times using data from a radiology information system: measuring radiologist reporting times. J Med Imaging Radiat Oncol 57(5):558–566. 10.1111/1754-9485.12092 10.1111/1754-9485.12092 [DOI] [PubMed] [Google Scholar]
- 46.Anderson LW, Krathwohl D (2001) A taxonomy for learning, teaching, and assessing: a revision of Bloom’s taxonomy of educational objectives, Complete. Longman, New York [Google Scholar]
- 47.Lourenco AP, Slanetz PJ, Baird GL (2023) Rise of ChatGPT: it may be time to reassess how we teach and test radiology residents. Radiology 307(5):e231053. 10.1148/radiol.231053 10.1148/radiol.231053 [DOI] [PubMed] [Google Scholar]
- 48.Bentley H, Diep Quoc Vo C, Zaki-Metias K, Nikpanah M (2023) Competency-based medical education in radiology graduate medical education: overview and future perspectives. Radiographics 43(5):e220197. 10.1148/rg.220197 10.1148/rg.220197 [DOI] [PubMed] [Google Scholar]
- 49.Coppola F, Faggioni L, Gabelloni M, De Vietro F, Mendola V, Cattabriga A, Cocozza MA, Vara G, Piccinino A, Lo Monaco S, Pastore LV, Mottola M, Malavasi S, Bevilacqua A, Neri E, Golfieri R (2021) Human, all too human? An all-around appraisal of the “artificial intelligence revolution” in medical imaging. Front Psychol 12:710982. 10.3389/fpsyg.2021.710982 10.3389/fpsyg.2021.710982 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Patel BN, Rosenberg L, Willcox G, Baltaxe D, Lyons M, Irvin J, Rajpurkar P, Amrhein T, Gupta R, Halabi S, Langlotz C, Lo E, Mammarappallil J, Mariano AJ, Riley G, Seekins J, Shen L, Zucker E, Lungren M (2019) Human-machine partnership with artificial intelligence for chest radiograph diagnosis. NPJ Digit Med 2:111. 10.1038/s41746-019-0189-7 10.1038/s41746-019-0189-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.